Effect of Enzogenol® Supplementation on Cognitive, Executive, and Vestibular/Balance Functioning in Chronic Phase of Concussion. Issue 1 (17th February 2017)

• Record Type: Journal Article
• Authors: Walter, A.; Finelli, K.; Bai, X.; Arnett, P.; Bream, T.; Seidenberg, P.; Lynch, S.; Johnson, B.; Slobounov, S.
• Is Part Of: Developmental neuropsychology. Volume 42:Issue 1/2(2017)
• Page Start: 93
• Page End: 103
• Publication Date: 2017-02-17
• Subjects: Neuropsychology -- Periodicals; 612.8
• DOI: 10.1080/87565641.2016.1256404
• Languages: English
• ISSNs: 8756-5641

Abstract

ABSTRACT: This study examined the feasibility of Enzogenol® as a potential treatment modality for concussed individuals with residual symptoms in the chronic phase. Forty-two student-athletes with history of sport-related concussion were enrolled, comparing Enzogenol® versus placebo. Testing was conducted using virtual reality (VR) and electroencephalography (EEG), with neuropsychological (NP) tasks primarily used to induce cognitive challenges. After six weeks, the Enzogenol® group showed enhanced frontal-midline theta, and decreased parietal theta power, indicating reduced mental fatigue. Subjects enrolled in the Enzogenol® group also self-reported reduced mental fatigue and sleep problems. This suggests that Enzogenol® has the potential to improve brain functioning in the chronic phase of concussion.